Khaled Elhady Mohamed

KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats

Kim Vietz Andreassen, Anna Thorsø Larsen, Nina Sonne et al. · Molecular Metabolism · 2021 · 36 citations · Full text

Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models

Anna Thorsø Larsen, Khaled Elhady Mohamed, Nina Sonne et al. · Biomedicine & Pharmacotherapy · 2022 · 33 citations · Full text

Glucose Homeostasis, Experimental Pharmacology, Gastrointestinal Peptide Hormone +21

Nanotechnologies for Intracellular Protein Delivery: Recent Progress in Inorganic and Organic Nanocarriers

Sarah Le Saux, Anne Aubert‐Pouëssel, Lyria Ouchait et al. · Advanced Therapeutics · 2021 · 28 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +29

Qualitative and quantitative analysis of the uptake of lipoplexes by villous placenta explants

Khair Alhareth, Lucie Valéro, Khaled Elhady Mohamed et al. · International Journal of Pharmaceutics · 2019 · 10 citations · Full text

Lipid Preparation, Villous Placenta Explants, Quantitative Analysis +3

Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic rats

Simone Anna Melander, Alexandra Louise Møller, Khaled Elhady Mohamed et al. · American Journal of Physiology-Endocrinology and Metabolism · 2023 · 10 citations · Full text